Search / Trial NCT06224725

Acrylamide and Health Outcomes

Launched by KAROLINSKA INSTITUTET · Jan 16, 2024

Trial Information

Current as of December 30, 2024

Recruiting

Keywords

Dementia Alzheimer Disease Parkinson Disease Myocardial Infarction Acrylamide Biomarkers

ClinConnect Summary

This clinical trial, titled "Acrylamide and Health Outcomes," is studying the potential health risks associated with acrylamide, a chemical that can form in foods during cooking and processing. Researchers want to find out if higher levels of acrylamide in the blood are linked to serious health issues like dementia, Alzheimer's disease, Parkinson's disease, and heart attacks. They will collect blood samples from around 2,145 participants over the course of 20 years to analyze the relationship between acrylamide exposure and these health conditions.

To participate in this study, you need to be an adult aged 18 or older and have your blood measured during the recruitment phase. However, if you currently have any of the diseases being studied, you won't be eligible to join. By participating, you will help researchers gather important information that could lead to safer food practices and better nutrition, which may ultimately reduce the risk of these diseases in the general population. The study will run from 2024 to 2028, and the findings could help shape public health recommendations in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • adults (18 years old)
  • blood measured at the recruitment
  • Exclusion Criteria:
  • prevalent cases of the diseases investigated

Trial Officials

Federica Laguzzi

Principal Investigator

Karolinska Instittutet

About Karolinska Institutet

Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.

Locations

Stockholm, , Sweden

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0